Recommendations on the management of multiple myeloma in 2020.
Acta Clin Belg
; 77(2): 445-461, 2022 Apr.
Article
in English
| MEDLINE | ID: covidwho-990458
ABSTRACT
With the introduction of immunomodulatory drugs, proteasome inhibitors, and anti-CD38 monoclonal antibodies, major improvements have been achieved in the treatment of multiple myeloma (MM), with a significant impact on the outcome of this disease. Different treatment combinations are now in use and other therapies are being developed. Based on an extensive review of the recent literature, we propose practical recommendations on myeloma management, to be used by hematologists as a reference for daily practice.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Multiple Myeloma
Type of study:
Prognostic study
Limits:
Humans
Language:
English
Journal:
Acta Clin Belg
Year:
2022
Document Type:
Article
Affiliation country:
17843286.2020.1860411
Similar
MEDLINE
...
LILACS
LIS